Actionable news
0
All posts from Actionable news
Actionable news in ABUS: ARBUTUS BIOPHARMA CORPORATION COMMON STOCK,

Confidential treatment order

> begin 644 filename1.pdf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md="" mr="" vt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end

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Tekmira Pharmaceuticals Corp makes a similar move, sign up!

Other recent filings from the company include the following:

Tekmira Pharmaceuticals: Additional Preclinical Combination Data To Be Presented This Year - April 22, 2016

Current report, items 8.01 and 9.01 - March 30, 2016